We caught up with Filipino hospital operator The Medical City and its plans for the GCC to meet the needs of the millions strong filipino diaspora. It also plans to target low paid workers from other countries.
New ehealth apps mean that the primary care sector in emerging markets can be profitably consolidated for the first time. We look at the potential, talk to advisers, investors and operators look and at what will be delivered in the next six months.
Daniel Antón, the CFO of Dentix, Spain’s largest dental chain with 2016 sales of over €258m, following the 2016 collapse of former leader Vitaldent, speaks to us about its business model in Spain, Italy and Latin America. Unlike the newly reborn Vitaldent, Dentix plans to grab new, apparently high risk, markets outside Spain. How?
Sanjeev Vashishta, former CEO of SRL, the largest international diagnostic group in India, speaks to us about his plans to build a new lab network, Path Kind, backed by Mankind Pharma Group, which he claims is India’s fourth largest pharmaceutical group.
The insurance group Aviva’s recent sale of part of its Hong Kong business to internet giant Tencent proved digital is the destination for China’s insurers. But it’s in health insurance that “digitalisation” will show its true worth predicts Thalia Georgiou, founder of the consultancy Asia Care Group.
UK-based occupational health provider Iqarus, which specialises in “demanding and complex operating environments”, has made its first international acquisition in Afghanistan. We speak to CEO Tim Mitchell about its plans in the war-torn state, and whether Donald Trump’s immigration policy could slash the lucrative market in health screenings needed to get US visas.
Apollo Hospitals Dhaka, a joint venture between its Indian namesake and the Bangladeshi STS Group, is Bangladesh’s first Joint Comission International accredited hospital. But Apollo’s chief of medical services Dr Prasad Muglikar tells Healthcare Nova it wasn’t costs or resources that were the main barrier to solving the problems of a lack of accountability and leadership on its wards – it was culture.
The Nairobi Hospital will add six outpatient centres and a 600-bed multi-specialty hospital to the growing list of healthcare infrastructure being built in the Kenyan capital this year and the next we heard today. CEO Gordon Odundo told Healthcare Nova the group is targeting the underserved population centres to the east of the city.
The Brazilian lab group, Hermes Pardini, will sell 40.2m shares with an indicative pricing of BRL17.50 to BRL21.50. At the upper bound, the company is valued at BRL864.3m (US$274m).
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
